Pittsburgh Pharmacy Investment Portfolio

This week in pharma, AbbVie is showing signs of a strong year. Skyrizi, their, recent collaboration with Boehringer Ingelheim, just got...

This week in pharma: On Tuesday, March 19, the FDA approved the first postpartum depression drug brexanolone (Zulresso—Sage...

Big news this week in pharma! the Trump administration appointed Dr. Ned Sharpless as the interim director of the FDA after Former...

This week in pharma: Johnson & Johnson’s esketamine, or Spravato, won the agency approval on Tuesday, March 5, 2019. Spravato is a nasal...

This week in Pharma, Akron Pharmaceuticals, which recently received 2 FDA manufacturing warnings, got hit with a form 483 for stability...

This week in pharma: Merck announced their data from three pivotal phase 3 trials focusing on treating advanced prostate cancer. The...